Our Patient Advocacy

What patient advocacy means to Day One.

The Patient Advocacy team at Day One works to ensure that the perspectives of patients and families inform company decision-making at every level. We do this by cultivating meaningful partnerships with the pediatric cancer community and bridging the gap between them and internal Day One teams. Together, we strive to advance our shared goals for the benefit of children with cancer and their families.

Together, it’s time to rethink pLGG.

Learn more about pediatric low-grade glioma (pLGG), the most common brain tumor in children.

Visit rethink pLGG

Supporting the Community

To ensure that we support the pediatric cancer community in the most meaningful and thoughtful way, we asked the community what matters most to them when engaging with a pharmaceutical company. What they shared is now reflected in our four Patient Advocacy Engagement Principles:

Communicate

Participate

Share Our Strengths

Be Inclusive

These Principles are based on mutual respect, transparent and authentic communications, and long-term partnerships and collaboration to take on the enormous challenges facing children with cancer and their families.

Christa Kerkorian
Vice President of Patient Advocacy

Christa Kerkorian

Vice President of Patient Advocacy

I lead the Patient Advocacy team at Day One. I partner with childhood cancer non-profit organizations, patients, and families to ensure that their experiences and insights are understood and considered by Day One teams, as we make decisions and develop new treatment options for children with cancer. The work we do impacts patients and families in that it helps Day One become better informed in how best to support the patients and families in everything we do—from clinical trials, to disease awareness/education, support services, public policy, and everything in between!

Close
Kelli Wright
Director of Patient Advocacy

Kelli Wright

Director of Patient Advocacy

As part of the Patient Advocacy team at Day One, working with the pediatric brain tumor community, I have the honor of connecting with patients, families and community leaders to learn what life is like with a brain tumor. This could include the diagnosis and treatment journey, the impact of side effects and survivorship/long-term effects, or life during or after treatment. That information is then shared with teams at Day One to ensure that the patient voice is heard as the company makes drug development and business decisions. For almost 11 years, I worked at CureSearch for Children’s Cancer, a national non-profit organization working to accelerate cures for children with cancer. While working with pharmaceutical leaders at CureSearch, I recognized the impact patients and families can have to improve the drug development process. Patient Advocacy is the connecter between patients and families and the teams within Day One. What we do every day will ultimately and directly impact the disease communities we serve.

Close